Brilliance. Ingenious. Learning.
Brilliance. Ingenious. Learning.
About the Talk
The Institute for Biomedical Gerontology in Tempe, Arizona is a volunteer operated rag-tag effort to cure human aging. In line with the methods of our parent organization, the Methuselah Foundation, we try to sustainably repair the damage that aging does to our bodies. We will introduce proof-of-concept stage research results from our portfolio, in areas such as macular degeneration, atherosclerosis, diabetes and immune system aging. In all these areas, university professors in their bureaucratic wisdom had been failing for decades to develop direct damage-repair approaches. When our volunteers got to work on the same problems, their out-of-the-box thinking lead to success on a shoestring budget, using ancient technology, in no time at all. However, our journey has only just begun. Our next challenges are to rally and professionalize our portfolio, and become a streamlined translational research facility. We need carry on developing our unconventional approach to the point where we can attract interest from deep-pocketed partners to make these therapies available to the aging patients of earth.
About the Presenter
“John Schloendorn has a master’s degree in biochemistry at the University of Tuebingen, Germany. Currently he is a graduate student at Arizona State University’s Biodesign Institute, USA. John is heavily involved in the LysoSENS project of the Methuselah Foundation, which aims to remove some intracellular waste products for example via microbe-derived hydrolases targeted to the lysosome. Yes, this is the aubreyesque way of thinking on and experimenting with life extension.” From an interview with John.
About the Conference
BIL2009 was held at CSULB in Long Beach, CA on Feb 13-14.
Loading ...
Interesting article about the inflammatory proteins involved in AMD.
http://www.sciencedaily.com/releases/2010/01/100104114549.htm